StockData
STVNNYSESurgical & Medical Instruments & Apparatus

Stevanato Group S.p.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026
$19.02+0.12 (+0.63%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2025
Ended Dec 31, 2025
Mar 4, 2026During market hours$346.00M$0.17$0.18
Q4 FY2024
Ended Dec 31, 2024
Mar 6, 2025During market hours$331.00M$0.18$0.19
Q4 FY2023
Ended Dec 31, 2023
Mar 7, 2024During market hours$320.60M$0.17$0.18
Q4 FY2022
Ended Dec 31, 2022
Mar 2, 2023Before market open–––

Company guidance

Outlook given with results on Mar 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Total capital expendituresnon-GAAPFY 2026270 to 290New
Adjusted EBITDA*non-GAAPFY 2026331.8 to 346.9New
Adjusted DEPS*non-GAAPFY 20260.59 to 0.63New
RevenueGAAPFY 20261.26 to 1.29New
Revenue at Constant Currencynon-GAAPFY 20261.278 to 1.308New

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Stevanato Group S.p.A. filed with the SEC